TNFRSF12A and prostate cancer: Similarly, in a prostate cancer xenograft model with bone metastatic DU145 RasG37 tumor cells, knockdown of Fn14 resulted in significantly reduced numbers of liver and brain tumors (Yin et al., 2014).